|
US2013309234A1
|
|
Correlation of de novo-induced tumor-associated humoral immune responses with improved clinical outcome
|
|
JP2012254994A
|
|
Antibody for cancer treatment, and combination with glucocorticoid
|
|
EP2578230A1
|
|
Removal of Tumor Cells from Intraoperative Autologous Blood Salvage
|
|
EP2241576A1
|
|
Use of trifunctional bispecific antibodies for the treatment of tumors associated with CD133+/EpCAM+ cancer stem cells
|
|
EP2033657A1
|
|
Intraoperative trifunctional antibody application for prophylatic intraperitonal tumour cell dissemination
|
|
EP1820513A1
|
|
Destruction of tumor cells expressing low to medium levels of tumor associated target antigens by trifunctional bispecific antibodies
|
|
EP1874821A1
|
|
Combination of antibodies and glucocorticoids for treating cancer
|
|
EP1666500A1
|
|
Use of trifunctionel antibodies to reduce the risk for GvHD in allogeneic antitumor cell therapy
|
